HA
Houman Ashrafian
Head of Research and Development at Sanofi
Greater London, England
Overview
Houman Ashrafian is the Executive Vice President and Head of Research and Development at Sanofi, with a significant background in medicine and a Doctor of Philosophy (Ph.D.) from the University of Oxford. He has held leadership positions at various organizations, including serving as Chairman of the Board at Weatherden and Mestag Therapeutics, and has made investments in prominent biotech companies like Therini Bio and Quell Therapeutics.
Ashrafian's career highlights include his role as Head of Experimental Therapeutics at the Radcliffe Department of Medicine at the University of Oxford and his current position at Sanofi, where he leads research and development efforts.
Work Experience
Executive Vice President, Head of Research and Development
2023 - Current
Chairman Of The Board
2016
Weatherden is a leading early clinical development company with a unique model providing partners with rapid, expert, high-quality drug development solutions. Facilitated by global relationships with external experts in all therapeutic areas, Weatherden’s experience extends to all aspects of translational drug discovery and development.
Head of Experimental Therapeutics - Radcliffe Department of Medicine
2014
Honorary Consultant Cardiologist / Co-lead inherited cardiac conditions service
2011
Chairman Of The Board
2020 - 2023
Director
2020 - 2023
Chairman Of The Board
2019 - 2023
Director
2018 - 2023
Investment Advisor
2018 - 2023
Managing Partner
2018 - 2023
Partner
2017 - 2018
Venture Partner
2016 - 2017
SV Health Investors is a boston-based venture capital firm focused on investments in biotechnology and healthcare industry.